BrightPath Biotherapeutics Company

BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies.
Industry: Peptides and Proteins
Headquarters: Kurume, Fukuoka, Japan
Founded Date: 2003-05-08
Employees Number: 1-10
Funding Status: IPO
Investors Number: 7
Total Funding: 11537153
Estimated Revenue: Less than $1M
Last Funding Date: 2014-08-29
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership